Catalyst

Slingshot members are tracking this event:

Thermo Fisher is buying Affymetrix for $1.3B ($14/share)

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
Importance
High Medium Low
Impact on Stocks
TMO

100%
AFFX

100%

Additional Information

Additional Relevant Details Affymetrix’s technologies enable parallel and multiplex analysis of biological systems at the cellular, protein and genetic level, facilitating the transition of research tools into clinical and applied markets. The company’s products are used by customers working in life sciences and translational research, molecular diagnostics, reproductive health and agricultural biotechnology. Based in Santa Clara, California, Affymetrix has approximately 1,100 employees worldwide and maintains sales and distribution operations primarily in the U.S., Europe and Asia. The business, which has annual revenues of approximately $350 million, will be integrated into Thermo Fisher’s Life Sciences Solutions Segment.
http://ir.thermofish...
Slingshot Insights Explained
Catalyst Date
Occurred on:
Jan 08, 2016
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Transaction, Antibodies, Eps, Genetic Analysis, Molecular Diagnostics, Agricultural Biotechnology, Reproductive Health